111 related articles for article (PubMed ID: 25075029)
1. Can expression of CXCL12 and CXCR4 be used to predict survival of gastric cancer patients?
Satomura H; Sasaki K; Nakajima M; Yamaguchi S; Onodera S; Otsuka K; Takahashi M; Muroi H; Shida Y; Ogata H; Okamoto K; Kato H
Anticancer Res; 2014 Aug; 34(8):4051-7. PubMed ID: 25075029
[TBL] [Abstract][Full Text] [Related]
2. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
[TBL] [Abstract][Full Text] [Related]
3. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis.
Tsuboi K; Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Nakayama G; Koike M; Fujiwara M; Yamamura Y; Nakao A
Oncol Rep; 2008 Nov; 20(5):1117-23. PubMed ID: 18949410
[TBL] [Abstract][Full Text] [Related]
4. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility?
Mitchell B; Leone D; Feller K; Menon S; Bondzie P; Yang S; Park HY; Mahalingam M
Hum Pathol; 2014 Oct; 45(10):2094-100. PubMed ID: 25130395
[TBL] [Abstract][Full Text] [Related]
5. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.
Ying J; Xu Q; Zhang G; Liu B; Zhu L
Med Oncol; 2012 Sep; 29(3):1716-22. PubMed ID: 21630055
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
7. CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer.
Izumi D; Ishimoto T; Miyake K; Sugihara H; Eto K; Sawayama H; Yasuda T; Kiyozumi Y; Kaida T; Kurashige J; Imamura Y; Hiyoshi Y; Iwatsuki M; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Takamori H; Araki N; Tan P; Baba H
Int J Cancer; 2016 Mar; 138(5):1207-19. PubMed ID: 26414794
[TBL] [Abstract][Full Text] [Related]
8. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Kawamoto A; Yasuda H; Inoue Y; Miki C; Kusunoki M
Ann Surg Oncol; 2010 Aug; 17(8):2051-8. PubMed ID: 20177796
[TBL] [Abstract][Full Text] [Related]
9. [Expression of chemokine receptor CXCR4 in colorectal carcinoma and its relationship with clinicopathological parameters].
Yu L; Shen Y; Li JK; Sun YH; Wang YC; Zhang JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):482-6. PubMed ID: 18803056
[TBL] [Abstract][Full Text] [Related]
10. Vascular CXCR4 expression - a novel antiangiogenic target in gastric cancer?
Ingold B; Simon E; Ungethüm U; Kuban RJ; Müller BM; Lupp A; Neumann U; Ebert MP; Denkert C; Weichert W; Schulz S; Röcken C
PLoS One; 2010 Apr; 5(4):e10087. PubMed ID: 20386750
[TBL] [Abstract][Full Text] [Related]
11. Expression of SNCG, MAP2, SDF-1 and CXCR4 in gastric adenocarcinoma and their clinical significance.
Zheng S; Shi L; Zhang Y; He T
Int J Clin Exp Pathol; 2014; 7(10):6606-15. PubMed ID: 25400739
[TBL] [Abstract][Full Text] [Related]
12. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
[TBL] [Abstract][Full Text] [Related]
16. Clinical implication of CXCL12 expression in gastric cancer.
Ishigami S; Natsugoe S; Okumura H; Matsumoto M; Nakajo A; Uenosono Y; Arigami T; Uchikado Y; Setoyama T; Arima H; Hokita S; Aikou T
Ann Surg Oncol; 2007 Nov; 14(11):3154-8. PubMed ID: 17653799
[TBL] [Abstract][Full Text] [Related]
17. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC; Paul S; Altorki NK; Saqi A
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):615-21. PubMed ID: 19258077
[TBL] [Abstract][Full Text] [Related]
18. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
[TBL] [Abstract][Full Text] [Related]
19. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
[TBL] [Abstract][Full Text] [Related]
20. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]